Hexapradol

Hexapradol
Clinical data
Other namesα-Butyl-β-hydroxy-β-phenylamphetamine; α-Pentyl-β-hydroxy-β-phenyl-2-phenethylamine; β-Phenyl-2-phenylheptanolamine
ATC code
  • None
Identifiers
  • 2-amino-1,1-diphenyl-1-heptanol
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC19H25NO
Molar mass283.415 g·mol−1
3D model (JSmol)
  • OC(c1ccccc1)(c2ccccc2)C(N)CCCCC
  • InChI=1S/C19H25NO/c1-2-3-6-15-18(20)19(21,16-11-7-4-8-12-16)17-13-9-5-10-14-17/h4-5,7-14,18,21H,2-3,6,15,20H2,1H3
  • Key:ZVRZJTRBWTVKOJ-UHFFFAOYSA-N

Hexapradol (INN) is a psychostimulant drug which was never marketed.[1]

It also had cytoprotective/antiulcer properties.[2]

Synthesis

Synthesis methods are described.[3]

See also

References

  1. ^ Ganellin CR, Triggle DJ (21 November 1996). Dictionary of Pharmacological Agents. Vol. 2. CRC Press. p. 1023. ISBN 978-0-412-46630-4. Retrieved 26 April 2012.
  2. ^ Scuri R, Mondani G, Fantini PL, Dàlla Valle V, Valsecchi B (September 1984). "Hexaprazol: a new antiulcer drug with a cytoprotective action". Bollettino Chimico Farmaceutico. 123 (9): 425–38. PMID 6529496.
  3. ^ GB 805511, "1,1-diaryl-2-aminoalkanols", published 1958-12-10, assigned to Mead Johnson & Co. 


This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.